查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945473

2026年盧克血液分離機全球市場報告

Leukapheresis Device Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，白血球分離設備的市場規模顯著成長，預計2025年將達到7億美元，到2026年將達到7.6億美元，複合年成長率為8.6%。過去幾年的成長可歸因於白血病和自體免疫疾病發生率的上升、幹細胞療法的引入、血液細胞分離技術的進步、臨床研究活動的增加以及醫院血球分離術服務的擴展。

預計未來幾年，白血球分離設備市場將維持強勁成長，2030年市場規模將達到10.1億美元，複合年成長率（CAGR）為7.4%。預測期內的成長要素包括：對攜帶式白血球分離系統的需求、人工智慧和自動化技術在設備中的應用、生物製藥研究的拓展、先進血球分離設備的監管核准以及精準醫療投資的增加。預測期內的關鍵趨勢包括：個人化白血球分離療法、微創血球分離技術、攜帶式和照護現場白血球分離設備、即時監測系統的整合以及自動化程度和工作流程效率的提高。

預計未來幾年，血液相關疾病發生率的上升將推動白血球分離器市場的成長。血液相關疾病是指影響血球結構和功能的疾病，會導致氧氣運輸、免疫系統功能和血液凝固的問題。這些疾病發生率的上升與人口老化密切相關，因為老年人更容易患貧血、白血病和其他血液疾病。白血球分離器透過選擇性地從血液中去除過量或異常的白血球來輔助治療這些疾病。這有助於緩解症狀並最大限度地減少白血病和自體免疫疾病的併發症。例如，根據澳洲非營利組織白血病基金會2024年3月發布的數據，約有19,500名澳洲人被診斷出罹患血液癌症，包括白血病、淋巴瘤和骨髓瘤。其中約43%的患者需要承擔高額的自費治療費用，42%的患者需要休假三個月以上。這凸顯了血液疾病發生率較往年上升，以及對患者及其家庭造成的經濟影響。因此，血液疾病的日益增多正在推動白血球分離器市場的擴張。

白血球分離設備市場的主要企業正加大對本地生產能力的投資，以改善治療設備的可近性並配合國家醫療衛生策略。建立本地生產設施有助於提高供應鏈效率，降低進口依賴，並提升先進血液和細胞採集系統的成本效益和可用性。例如，2024年11月，美國醫療技術公司泰爾Terumo Corporation Blood & Cell Technologies, Inc.）與其中國子公司Terumo Medical Corp.產品（杭州）有限公司合作，在杭州啟動在地化生產。該計畫專注於生產關鍵的白血球分離產品，例如Trima Accel全自動血液採集系統和Spectra Optia血液分離系統，這些產品在中國廣泛應用於治療性血液分離、幹細胞採集和血液成分分離等操作。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球盧克血液分離機市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 生物技術、基因組學和精準醫學
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 個人化白血球分離療法
    • 微創血液分離技術
    • 攜帶式和照護現場白血球分離器
    • 即時監控系統整合
    • 自動化和工作流程效率

第5章 終端用戶產業市場分析

  • 醫院
  • 學術研究機構
  • 製藥公司
  • 血液成分供應商
  • 血液中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球盧克血液分離設備市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球盧克血液分離設備市場規模、對比及成長率分析
  • 全球盧克血液分離設備市場表現：規模與成長，2020-2025年
  • 全球盧克血液分離設備市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依設備類型
  • 治療性白血球分離、細胞分離、幹細胞採集、研究應用、白血球分離柱及細胞分離裝置、白血球分離拋棄式、血球分離裝置
  • 按組件
  • 白血球分離器、採血組、醫療耗材、過濾器
  • 最終用戶
  • 醫院、學術研究機構、製藥和生物技術公司、血液成分供應商、血站
  • 按類型細分：治療性白血球分離術
  • 白血病治療系統、敗血症治療用白血球清除裝置、自體免疫疾病管理裝置
  • 依類型細分：細胞分離術
  • 血小板分離器、淋巴球分離器、紅血球分離器
  • 依類型細分：幹細胞採集
  • 周邊血幹細胞（PBSC）採集裝置、臍帶血採集系統、骨髓幹細胞分離系統
  • 按類型細分：研究用途
  • 用於研發的細胞分離系統、用於臨床試驗的血球分離平台、用於學術實驗室的白血球分離器
  • 按類型細分：白血球分離柱和細胞分離裝置
  • 吸附柱、膜細胞分離系統、離心細胞分離裝置
  • 依類型細分：白血球分離用拋棄式產品
  • 輸液管組件、針頭和導管、收集袋
  • 按類型細分：血液分離機
  • 連續式血漿分離機、攜帶式或移動式血漿分離裝置、間歇式血漿分離系統

第10章 區域與國家分析

  • 全球盧克血液分離設備市場：按地區、業績和預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球盧克血液分離設備市場：依國家、性能及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 盧克血液分離機市場：競爭格局與市場佔有率，2024 年
  • 盧克血液分離設備市場：公司估值矩陣
  • 盧克血液分離設備市場：公司簡介
    • Fresenius SE and Co. KGaA
    • Asahi Kasei Medical Co. Ltd
    • Baxter International Inc.
    • Grifols SA
    • TERUMO BCT INC.

第37章：其他領先和創新企業

  • Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年盧克血液分離設備市場：提供新機會的國家
  • 2030年盧克血液分離設備市場：提供新機會的細分市場
  • 2030年盧克血液分離設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME5MLDEV05_G26Q1

A leukapheresis device is a specialized medical tool designed to selectively isolate and collect white blood cells (leukocytes) from the blood of a patient or donor through centrifugation or filtration methods. It serves an essential function in therapies such as leukemia treatment, stem cell transplantation, and autoimmune disorder management, and is also utilized in clinical research and diagnostic procedures.

The primary categories of leukapheresis devices include therapeutic leukapheresis, cytapheresis, stem cell collection, research applications, leukapheresis columns and cell separators, leukapheresis disposables, and apheresis devices. Therapeutic leukapheresis is a medical technique employed to extract surplus or abnormal white blood cells from the bloodstream, aiming to alleviate symptoms or avoid related complications. These systems comprise various elements, including leukapheresis machines, blood collection sets, medical consumables, and filtration components. The diverse group of end users includes hospitals, academic and research organizations, pharmaceutical and biotechnology firms, blood centers, and providers of blood components.

Tariffs have influenced the leukapheresis device market by affecting the cost of imported medical equipment, consumables, and advanced apheresis components. This has increased production and operational costs, particularly impacting segments such as leukapheresis machines, disposable kits, and research-focused apheresis platforms in regions like North America and Europe. While the tariffs pose challenges in terms of supply chain delays, they also encourage local manufacturing and sourcing strategies, enabling some domestic players to capture market share and invest in innovation for cost-efficient leukapheresis solutions.

The leukapheresis device market research report is one of a series of new reports from The Business Research Company that provides leukapheresis device market statistics, including leukapheresis device industry global market size, regional shares, competitors with a leukapheresis device market share, detailed leukapheresis device market segments, market trends and opportunities, and any further data you may need to thrive in the leukapheresis device industry. This leukapheresis device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The leukapheresis device market size has grown strongly in recent years. It will grow from $0.7 billion in 2025 to $0.76 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rising prevalence of leukemia and autoimmune disorders, adoption of stem cell therapies, advancements in blood cell separation technology, increasing clinical research activities, growth of hospital-based apheresis services.

The leukapheresis device market size is expected to see strong growth in the next few years. It will grow to $1.01 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to demand for portable leukapheresis systems, integration of ai and automation in devices, expansion of biopharmaceutical research, regulatory approvals for advanced apheresis devices, rising investments in precision medicine. Major trends in the forecast period include personalized leukapheresis treatments, minimally invasive apheresis techniques, portable and point-of-care leukapheresis devices, integration of real-time monitoring systems, enhanced automation and workflow efficiency.

The increasing incidence of blood-related disorders is expected to drive the growth of the leukapheresis device market in the coming years. Blood-related disorders are medical conditions that affect the structure or function of blood cells, leading to issues with oxygen transport, immune system performance, or blood clotting. The growing prevalence of these disorders is largely linked to an aging population, as older adults are more prone to conditions such as anemia, leukemia, and other hematological diseases. Leukapheresis devices support the treatment of these disorders by selectively removing excess or abnormal white blood cells from the blood, thereby helping to relieve symptoms and minimize complications in illnesses like leukemia and autoimmune disorders. For example, in March 2024, the Leukaemia Foundation, an Australia-based non-profit organization, reported that approximately 19,500 Australians were diagnosed with blood cancers, including leukemia, lymphoma, and myeloma, with nearly 43% facing substantial out-of-pocket treatment expenses and 42% needing more than three months off work. This highlights both the rising occurrence and the financial impact on patients and their families compared to previous years. Consequently, the growing prevalence of blood-related disorders is fueling the expansion of the leukapheresis device market.

Key players in the leukapheresis device market are increasingly investing in regional production capabilities to improve access to therapeutic devices and align with national healthcare strategies. Establishing local manufacturing facilities helps to streamline supply chains, reduce reliance on imports, and enhance the affordability and availability of advanced blood and cell collection systems. For instance, in November 2024, Terumo Blood and Cell Technologies, a US-based medical technology firm, collaborated with its China-based subsidiary, Terumo Medical Products (Hangzhou) Co., Ltd., to initiate localized production in Hangzhou. This initiative focuses on producing vital leukapheresis products, such as the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, which are widely used in China for procedures including therapeutic apheresis, stem cell collection, and blood component separation.

In November 2025, Terumo Blood and Cell Technologies (Terumo BCT), a US-based medical technology company, joined forces with Santersus AG to advance an innovative therapeutic apheresis technology aimed at enhancing clinical outcomes for patients with sepsis. Through this collaboration, Terumo BCT and Santersus plan to integrate Santersus' NucleoCapture blood purification device with Terumo BCT's Spectra Optia(TM) Apheresis System to selectively remove neutrophil extracellular traps (NETs) from the blood, potentially lowering sepsis-related mortality and improving patient care. Santersus AG, based in Switzerland, specializes in therapeutic apheresis and develops medical devices for blood purification in critically ill patients.

Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva, BioSafe Group SA, Terumo Corporation

North America was the largest region in the leukapheresis device market in 2025. The regions covered in the leukapheresis device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the leukapheresis device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The leukapheresis device market consists of sales of leukapheresis software and monitoring systems, blood flow controllers and pumps, and centrifuge rotors and tubing sets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Leukapheresis Device Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses leukapheresis device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for leukapheresis device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The leukapheresis device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Device Type: Therapeutic Leukapheresis; Cytapheresis; Stem Cell Collection; Research Applications; Leukapheresis Columns and Cell Separators; Leukapheresis Disposables; Apheresis Devices
  • 2) By Component: Leukapheresis Machine; Blood Collection Set ; Medical Consumables ; Filters
  • 3) By End User: Hospitals; Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Blood Component Providers; Blood Centers
  • Subsegments:
  • 1) By Therapeutic Leukapheresis: Leukemia Treatment Systems; Sepsis Treatment Leukapheresis Units; Autoimmune Disease Management Devices
  • 2) By Cytapheresis: Plateletpheresis Devices; Lymphapheresis Units; Erythrocytapheresis Systems
  • 3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices; Umbilical Cord Blood Collection Systems; Bone Marrow Stem Cell Apheresis Systems
  • 4) By Research Applications: Cell Separation Systems for Research and Development; Clinical Trial Apheresis Platforms; Academic Laboratory Leukapheresis Devices
  • 5) By Leukapheresis Columns And Cell Separators: Adsorption Columns; Membrane-Based Cell Separation Systems; Centrifugal Cell Separators
  • 6) By Leukapheresis Disposables: Tubing Sets; Needles And Catheters; Collection Bags
  • 7) By Apheresis Devices: Continuous Flow Apheresis Machines; Portable Or Mobile Apheresis Units; Intermittent Flow Apheresis Systems
  • Companies Mentioned: Fresenius SE and Co. KGaA; Asahi Kasei Medical Co. Ltd; Baxter International Inc.; Grifols S.A.; TERUMO BCT INC.; Kaneka Corporation; Nikkiso Co. Ltd; Haemonetics Corporation; Miltenyi Biotec GmbH; Macopharma; B. Braun Melsungen AG; Kawasumi Laboratories Inc.; Beijing Zksk Technology Co. Ltd; Puriblood Medical Co. Ltd; Fresenius Kabi AG; JMS Co. Ltd; HemaCare Corporation; Medica Group PLC; LivaNova PLC; Cytiva; BioSafe Group SA; Terumo Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Leukapheresis Device Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Leukapheresis Device Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Leukapheresis Device Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Leukapheresis Device Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Personalized Leukapheresis Treatments
    • 4.2.2 Minimally Invasive Apheresis Techniques
    • 4.2.3 Portable And Point-Of-Care Leukapheresis Devices
    • 4.2.4 Integration Of Real-Time Monitoring Systems
    • 4.2.5 Enhanced Automation And Workflow Efficiency

5. Leukapheresis Device Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Academic Research Institutes
  • 5.3 Pharmaceutical Companies
  • 5.4 Blood Component Providers
  • 5.5 Blood Centers

6. Leukapheresis Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Leukapheresis Device Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Leukapheresis Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Leukapheresis Device Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Leukapheresis Device Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Leukapheresis Device Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Leukapheresis Device Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Leukapheresis Device Market Segmentation

  • 9.1. Global Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices
  • 9.2. Global Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Leukapheresis Machine, Blood Collection Set, Medical Consumables, Filters
  • 9.3. Global Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers
  • 9.4. Global Leukapheresis Device Market, Sub-Segmentation Of Therapeutic Leukapheresis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices
  • 9.5. Global Leukapheresis Device Market, Sub-Segmentation Of Cytapheresis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems
  • 9.6. Global Leukapheresis Device Market, Sub-Segmentation Of Stem Cell Collection, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems
  • 9.7. Global Leukapheresis Device Market, Sub-Segmentation Of Research Applications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices
  • 9.8. Global Leukapheresis Device Market, Sub-Segmentation Of Leukapheresis Columns And Cell Separators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators
  • 9.9. Global Leukapheresis Device Market, Sub-Segmentation Of Leukapheresis Disposables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tubing Sets, Needles And Catheters, Collection Bags
  • 9.10. Global Leukapheresis Device Market, Sub-Segmentation Of Apheresis Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems

10. Leukapheresis Device Market Regional And Country Analysis

  • 10.1. Global Leukapheresis Device Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Leukapheresis Device Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Leukapheresis Device Market

  • 11.1. Asia-Pacific Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Leukapheresis Device Market

  • 12.1. China Leukapheresis Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Leukapheresis Device Market

  • 13.1. India Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Leukapheresis Device Market

  • 14.1. Japan Leukapheresis Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Leukapheresis Device Market

  • 15.1. Australia Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Leukapheresis Device Market

  • 16.1. Indonesia Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Leukapheresis Device Market

  • 17.1. South Korea Leukapheresis Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Leukapheresis Device Market

  • 18.1. Taiwan Leukapheresis Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Leukapheresis Device Market

  • 19.1. South East Asia Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Leukapheresis Device Market

  • 20.1. Western Europe Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Leukapheresis Device Market

  • 21.1. UK Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Leukapheresis Device Market

  • 22.1. Germany Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Leukapheresis Device Market

  • 23.1. France Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Leukapheresis Device Market

  • 24.1. Italy Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Leukapheresis Device Market

  • 25.1. Spain Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Leukapheresis Device Market

  • 26.1. Eastern Europe Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Leukapheresis Device Market

  • 27.1. Russia Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Leukapheresis Device Market

  • 28.1. North America Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Leukapheresis Device Market

  • 29.1. USA Leukapheresis Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Leukapheresis Device Market

  • 30.1. Canada Leukapheresis Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Leukapheresis Device Market

  • 31.1. South America Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Leukapheresis Device Market

  • 32.1. Brazil Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Leukapheresis Device Market

  • 33.1. Middle East Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Leukapheresis Device Market

  • 34.1. Africa Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Leukapheresis Device Market Regulatory and Investment Landscape

36. Leukapheresis Device Market Competitive Landscape And Company Profiles

  • 36.1. Leukapheresis Device Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Leukapheresis Device Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Leukapheresis Device Market Company Profiles
    • 36.3.1. Fresenius SE and Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Asahi Kasei Medical Co. Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. TERUMO BCT INC. Overview, Products and Services, Strategy and Financial Analysis

37. Leukapheresis Device Market Other Major And Innovative Companies

  • Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva

38. Global Leukapheresis Device Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Leukapheresis Device Market

40. Leukapheresis Device Market High Potential Countries, Segments and Strategies

  • 40.1 Leukapheresis Device Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Leukapheresis Device Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Leukapheresis Device Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer